CABA

Cabaletta Bio Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth↓ 2/10
  • Momentum↑ 8/10
Cabaletta Bio sales and earnings growth
CABA Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -17.13%
  • FCF Y/Y↓ -43.91%
Cabaletta Bio gross and profit margin trends
CABA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -298.40%
Cabaletta Bio net debt vs free cash flow
CABA Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -71.1

Cabaletta Bio stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗